DeltaShares S&P International Managed Risk ETF (DMRI) is an exchange-traded fund incorporated in the USA that seeks to track the performance, before fees and expenses, of the S&P EPAC Ex-Korea LargeMidCap Managed Risk 2.0 Index; the fund invests substantially all of its assets in securities comprising the underlying index, including growth and value stocks across diversified market capitalizations in Europe, Australasia, and the Far East excluding Korea, supplemented by fixed income holdings such as 5-year U.S. Treasury futures for risk management; it may employ derivatives including futures, ETFs, options, and warrants on equities to achieve its objectives with a low turnover rate of approximately 1%.
The ETF targets investors seeking managed risk exposure to international developed equity markets outside the U.S. and Korea, focusing on large- and mid-cap companies; its portfolio includes top holdings such as Nestle SA (NESN), ASML Holding NV, Roche Holding AG, Novartis AG, and Toyota Motor Corp; assets under management stand at approximately $152 million.
DeltaShares operates as a brand under Transamerica Asset Management, Inc., with index provision and risk management support from Milliman Financial Risk Management LLC and S&P Dow Jones Indices LLC; the broader DeltaShares suite encompasses similar managed risk ETFs tracking S&P 500, S&P 400, S&P 600, and emerging markets indices; distribution is handled by Foreside Fund Services, LLC.
The ETF launched as part of the inaugural DeltaShares suite debuted by Transamerica, with subsequent expansions including the S&P EM 100 & Managed Risk ETF; no major recent partnerships, acquisitions, funding rounds, or operational changes specific to DMRI or DeltaShares have been reported in the last 1-2 years amid a stable product lineup.